Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
2.
J Nanosci Nanotechnol ; 6(9-10): 3222-5, 2006.
Article in English | MEDLINE | ID: mdl-17048540

ABSTRACT

Magnetic nanoparticles can be used in medicine in vivo as contrast agents and as a drug carrier system for chemotherapeutics. Thus local cancer therapy is performed with Magnetic Drug Targeting (MDT) and allows a specific delivery of therapeutic agents to desired targets, i.e., tumors, by using a chemotherapeutic substance bound to magnetic nanoparticles and focused with an external magnetic field to the tumor after intraarterial application. Important for this therapeutic principle is the distribution of the particles in the whole organism and especially in the tumor. Therefore we used magnetorelaxometry to quantify ferrofluids delivered after MDT. Tissue samples of some mm3 volume of a VX2 squamous cell carcinoma were measured by magnetic relaxation and the amount of iron was determined using the original ferrofluid suspension as a reference. From this the distribution of the magnetic particles within the slice of tumor was reconstructed. Histological cross-sections of the respective tumor offer the opportunity to map quantitatively the particle distribution and the vascularisation in the targeted tumor on a microscopic scale. Our data show that the integral method magnetorelaxometry and microscopic histological methods can complete each other efficiently.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Drug Delivery Systems/methods , Magnetics/therapeutic use , Nanostructures/analysis , Nanostructures/ultrastructure , Animals , Cell Line, Tumor , Nanostructures/chemistry , Particle Size , Rabbits
3.
J Nanosci Nanotechnol ; 6(9-10): 2762-8, 2006.
Article in English | MEDLINE | ID: mdl-17048480

ABSTRACT

In recent years biomedical research indicated, that magnetic nanoparticles can be a promising tool for several applications in vitro and in vivo. In medicine many approaches were investigated for diagnosis and therapy and offered a great variety of applications. Magnetic cell separation, magnetic resonance imaging (MRI), magnetic targeted delivery of therapeutics or magnetically induced hyperthermia are approaches of particular clinical relevance. For medical use, especially for in vivo application it is of great importance that these particles do not have any toxic effects or incompatibility with biological organism. Investigations on applicable particles induced a variability of micro- and nanostructures with different materials, sizes, and specific surface chemistry.


Subject(s)
Drug Delivery Systems/methods , Hyperthermia, Induced/methods , Immunomagnetic Separation/methods , Magnetics/therapeutic use , Nanoparticles/chemistry , Nanoparticles/ultrastructure , Drug Delivery Systems/instrumentation , Hyperthermia, Induced/instrumentation , Immunomagnetic Separation/instrumentation
4.
Endothelium ; 12(4): 185-91, 2005.
Article in English | MEDLINE | ID: mdl-16162441

ABSTRACT

Cardiovascular disease is rare in premenopausal women compared to men. The authors investigate sex hormone-induced endothelin-1 (ET-1) release and the involvement of classic sex hormone receptors as well as the ability of sigma-1/cocaine receptors to respond to sex hormones. ET-1 release was measured in the supernatant of endothelial cells after treatment with beta-estradiol, progesterone, testosterone, or combined with their antagonists, and with the sigma-1 receptor ligand ditolylguanidine (DTG), or haloperidol, a sigma-1 receptor antagonist. Binding assays were performed using 2.5 x 10(-8) M [3H]DTG. Female sex hormones decreased ET-1 release whereas testosterone increased it, sex hormone antagonists only slightly attenuated or had no effect on the respective hormone's effect. DTG totally blocked the female sex hormone-induced inhibition on ET-1 release, whereas testosterone-induced stimulation was not affected. However, haloperidol blocked both. [3H]DTG binding was displaced by beta -estradiol but not by testosterone. DTG-binding sites account for 513 +/- 114 per cell, KD 8.79 nM. These data suggest that besides classic steroid hormone receptors, sigma-1/cocaine receptors mediate the effects of female sex hormones on ET-1 release, an up to now unknown signalling pathway. Results also suggest that female and male sex hormones may bind to different sites on sigma-1 receptors, exerting opposite pharmacological effects.


Subject(s)
Carrier Proteins/physiology , Endothelial Cells/drug effects , Endothelin-1/metabolism , Estradiol/pharmacology , Receptors, Drug/physiology , Receptors, Steroid/physiology , Receptors, sigma/physiology , Animals , Dose-Response Relationship, Drug , Down-Regulation/drug effects , Down-Regulation/physiology , Endothelial Cells/metabolism , Female , Humans , Progesterone/pharmacology , Receptors, Steroid/drug effects , Receptors, sigma/drug effects , Swine , Testosterone/pharmacology
5.
Verh Dtsch Ges Pathol ; 88: 170-3, 2004.
Article in German | MEDLINE | ID: mdl-16892549

ABSTRACT

A major challenge in stem cell biology is to study the underlying mechanisms of tissue specific homing and differentiation. Recent results suggest that bone marrow derived stem cells can give rise to multiple cell types. Because chemokines and chemokine receptors are associated with development, differentiation and homing of immune cells, we undertook efforts to study the chemokine receptor expression profile of human adult stem cells to identify their potential role in tissue specific homing prior to transdifferentiation. Using human bone marrow-derived stem cell lines, we could demonstrate functional chemokine receptor expression of various chemokine receptors. The expression of CXCR5 and CCR7, associated with secondary lymphoid organ homing as well as CXCR4 and CCR10, involved in organ specific homing and CXCR3, CCR5 and CCR1, which are involved in inflammation events, suggested a role of chemokine receptors in tissue specific homing of stem cells. To proof the specific homing of stem cells in vivo, we used murine stem cell lines, stably introduced green fluorescent protein under control of CMV promotor into the cells and injected them intravenously into mice. We demonstrate the homing of these stem cells to lymphnode and thymus as well as mucosal tissue, while stem cells home exclusively to a site of lesion during wound healing and tissue regeneration. Our data suggest that chemokine biology may play a pivotal role in the homing of stem cells to specific tissues and niches prior to (trans)differentiation, while the homing changes during tissue damage and other adequate lesions.


Subject(s)
Chemokines/physiology , Regeneration/physiology , Stem Cell Transplantation , Wound Healing/physiology , Adult , Animals , Female , Flow Cytometry , Humans , Mice , Mice, Inbred CBA , Models, Animal , Stem Cells/cytology , Stem Cells/physiology
6.
Brain Lang ; 76(2): 81-110, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11254251

ABSTRACT

There are both theoretical and empirical reasons to support the hypothesis that dyslexia is associated with enhancement of right-hemisphere, visual-spatial skills. However, the neurological evidence is neutral with respect to whether dyslexic visual-spatial abilities should be superior (a compensation model) or inferior (a deficit model). In three studies we tested the hypothesis that dyslexia is associated with superior visual-spatial skills. Individuals with dyslexia not only failed to show superiority on a range of visual-spatial tasks, even when tasks were presented without time constraints, but also demonstrated a deficit on many tasks. Whereas we found attentional problems associated with dyslexia, these did not explain our findings. Results are discussed in terms of the apparent conflict between the failure to find any visual-spatial talent associated with dyslexia and the fact that dyslexia is overrepresented in certain visual-spatial professions.


Subject(s)
Aptitude , Dyslexia/diagnosis , Space Perception , Visual Perception , Adult , Cognition , Female , Humans , Male , Neuropsychological Tests
7.
Electrophoresis ; 21(13): 2729-36, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10949152

ABSTRACT

Elongation factor 2 (EF-2) catalyses the last step of the elongation cycle, translocation, in the course of protein biosynthesis. A system for analyzing post-translational modifications of EF-2, which is a single polypeptide of 857 amino acids, is reported and its application to cytosolic extracts of cultured neonatal rat heart myocytes, neonatal and adult rat cardiac tissue, and extracts of human left ventricular myocardium is described. Comparing different pH ranges in immobilized pH gradient-isoelectric focusing (IPG-IEF), a range of pH 3 - 10 and 4 - 9 resulted in a highly defined and reproducible resolution of six different EF-2 variants of all extracts in the first dimension. These six variants were detected by the "imaging plate" (phosphor radiation image sensor) after specific labeling with Pseudomonas exotoxin A catalyzed [32P]ADP-ribosylation. This finding could be confirmed in Western blot analysis with a specific polyclonal rabbit antibody. Using two-dimensional polyacrylamide gel electrophoresis (2-D-PAGE), five to six EF-2 variants could be demonstrated in all extracts. By application of a second IPG indicator strip to the 2-D gel, they could be aligned with corresponding spots in a silver-stained 2-D separation of human myocardial tissue, revealing that the EF-2 variants belong to the group of low-abundance proteins.


Subject(s)
Myocardium/chemistry , Peptide Elongation Factor 2/chemistry , Protein Processing, Post-Translational , Adenosine Diphosphate Ribose/analysis , Animals , Animals, Newborn , Autoradiography/instrumentation , Blotting, Western , Cardiomyopathy, Dilated/metabolism , Cells, Cultured , Cytosol/chemistry , Electrophoresis, Gel, Two-Dimensional/methods , Electrophoresis, Polyacrylamide Gel , Humans , Hydrogen-Ion Concentration , Isoelectric Focusing , Peptide Elongation Factor 2/isolation & purification , Phosphorylation , Rats , Rats, Wistar , Silver Staining , Species Specificity
8.
Circulation ; 98(5): 385-90, 1998 Aug 04.
Article in English | MEDLINE | ID: mdl-9714087

ABSTRACT

BACKGROUND: Cocaine-associated vascular events are not completely explained by adrenergic stimulation. The purposes of this study were to investigate whether vasoconstrictive endothelin-1 is released by cocaine and to elucidate the mechanisms involved. METHODS AND RESULTS: Endothelin-1 was measured by radioimmunoassay and high-performance liquid chromatography (1) in the supernatant of porcine aortic endothelial cells after treatment with cocaine (10(-7) to 10(-4) mol/L) and a sigma-receptor antagonist, haloperidol (10(-6) mol/L) or ditolylguanidine (10(-5) mol/L) and (2) in plasma and urine of 12 cocaine-intoxicated patients and 13 healthy control subjects. Radioligand binding assays were performed on endothelial membrane preparations. In cell culture, cocaine significantly increased endothelin accumulation above baseline at 3 to 24 hours; endothelin release rates per hour increased dose-dependently, reaching a plateau of 175+/-23% of control at hour 4 to 5. Coincubation of cocaine with haloperidol or ditolylguanidine abolished or reduced cocaine-induced endothelin release. Endothelial membrane preparations specifically and displaceably bound the highly selective sigma-ligand [3H]ditolylguanidine (25x10(-9) mol/L), with 1400 binding sites estimated per cell. Endothelin-1 levels in plasma (22.7+/-5.6 versus 7.3+/-0.8 pmol/L) and urine (41.5+/-10.1 versus 12.7+/-3.8 pmol/L) of cocaine-intoxicated patients were significantly increased compared with control values. CONCLUSIONS: The data suggest that cocaine increases the endothelin-1 release in vitro and in vivo. The cocaine-induced vasoconstriction/vasospasm may therefore be facilitated by the release of endothelin-1. Cocaine appears to be an exogenous stimulator at endothelial sigma-receptors. The endogenous ligands of this antiopioid system may prove to play a role in vasospastic angina, acute myocardial infarction, and sudden cardiac death.


Subject(s)
Cocaine/pharmacology , Endothelin-1/drug effects , Endothelium, Vascular/drug effects , Receptors, sigma/agonists , Receptors, sigma/drug effects , Vasoconstrictor Agents/pharmacology , Acute Disease , Adolescent , Adult , Animals , Cells, Cultured , Cocaine-Related Disorders/blood , Cocaine-Related Disorders/urine , Dose-Response Relationship, Drug , Endothelin-1/analysis , Endothelin-1/metabolism , Endothelium, Vascular/metabolism , Female , Humans , Male , Swine , Time Factors
9.
Semin Interv Cardiol ; 3(3-4): 177-83, 1998.
Article in English | MEDLINE | ID: mdl-10406690

ABSTRACT

Neointimal formation after stent implantation can cause luminal narrowing, called restenosis. Restenosis is induced by initial platelet adhesion and thrombus formation followed by immunocyte adhesion on the stent surface and on the injured vessel wall. The thrombus releases factors, which activates the proliferation of smooth muscle cells. Stents, coated with an antithrombotic surface, may prevent platelet adhesion and subsequent smooth muscle cell proliferation. This paper will review stent coating with poly-LD-lactic acid, a biodegradable polymer containing Iloprost, a synthetic prostacycline, and PEG-Hirudin as a method for reducing of restenosis.


Subject(s)
Antithrombins/therapeutic use , Coated Materials, Biocompatible , Hirudins/analogs & derivatives , Iloprost/therapeutic use , Platelet Aggregation Inhibitors/therapeutic use , Stents , Animals , Coronary Disease/therapy , Coronary Vessels/pathology , Drug Combinations , Drug Delivery Systems , Hirudin Therapy , Humans , Lactic Acid/therapeutic use , Platelet Adhesiveness , Polyesters , Polymers/therapeutic use , Secondary Prevention
10.
J Mol Cell Cardiol ; 29(2): 799-811, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9140836

ABSTRACT

To elucidate cellular mechanisms of myocardial depression in Pseudomonas sepsis the effects of sublethal concentrations of P. aeruginosa exotoxin A--a main virulence factor--were studied in cultured neonatal rat cardiomyocytes. It is known that this toxin exerts its pathogenic effect by inhibition of protein synthesis via ADP-ribosylation and thereby inactivation of elongation factor 2 (EF-2). Within 48 72 h, half maximal inhibition of protein synthesis occurs at 4-10 ng/ml. The toxin prevents the beta-adrenoceptor(AR)-mediated myosin heavy chain isozyme shift (V3/V1), while the T3-induced myosin shift is not suppressed. While beta 1-AR-downregulation by excess of norepinephrine (NE) is not affected, protein synthesis-dependent receptor upregulation in the recover period after removal of NE is completely suppressed by P. aeruginosa exotoxin A. Thus, a non-lethal, partial inhibition of global cellular protein synthesis by P. aeruginosa exotoxin A: (1) completely prevents beta 1-AR-mediated myosin isozyme shift and beta-AR upregulation: (2) sustains the cardiomyocytes in a catecholamine-refractory contractile state in the recovery period after catecholamine desensitization: (3) suggests cellular mechanisms by which P. aeruginosa exotoxin A might impair heart function in Pseudomonas sepsis: and (4) may help reveal the possible influence of endogenous inhibitors of EF-2.


Subject(s)
ADP Ribose Transferases , Bacterial Toxins , Catecholamines/pharmacology , Exotoxins/pharmacology , Myocardium/cytology , Protein Biosynthesis , Virulence Factors , Adrenergic alpha-Agonists/pharmacology , Adrenergic beta-Agonists/pharmacology , Animals , Cells, Cultured , Cytotoxins/toxicity , Dose-Response Relationship, Drug , Exotoxins/toxicity , Isoproterenol/pharmacology , Myocardial Contraction/drug effects , Myocardium/metabolism , Norepinephrine/pharmacology , Proteins/drug effects , Rats , Rats, Sprague-Dawley , Receptors, Adrenergic, beta-1/drug effects , Receptors, Adrenergic, beta-1/metabolism , Triiodothyronine/pharmacology , Pseudomonas aeruginosa Exotoxin A
11.
Allerg Immunol (Leipz) ; 26(4): 368-74, 1980.
Article in German | MEDLINE | ID: mdl-6452045

ABSTRACT

Circulating human breast tumor-associated antigen (TAA) specific lymphocytes were detected in breast carcinoma patients by antigen specific rosette technique. About 60 percent of patients with breast cancer showed a positive reaction in our test system, the number of rosettes were considerably increased in comparison to the values of blood donors. Following operation normally the number of TAA specific rosettes decrease, contrary, in all cases with recidives, tested, we found positive test results. There is evidence, that our modification of the specific rosette-technique is suitable for detection of malignomas and can be important for the postoperative control of patients with breast carcinoma.


Subject(s)
Antigens, Neoplasm , Breast Neoplasms/immunology , Lymphocytes/immunology , Humans , Rosette Formation
SELECTION OF CITATIONS
SEARCH DETAIL
...